- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 11, 2026 | 34.28M sh |
| Stock Issued | Q2 2026 · Mar 31, 2026 | 0 sh |
| Stock Issued | Q2 2026 · Mar 31, 2025 | 0 sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 34.28M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 34.28M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 34.28M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 34.28M sh |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$89.35K |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$80.32K |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $15.05K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $234.41K |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $244.72K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $100.04K |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | −$298.29K |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$207.16K |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $313.34K |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $474.8K |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $313.34K |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $474.8K |
| Current Assets | Q2 2026 · Mar 31, 2026 | $15.05K |
| Current Assets | Q2 2026 · Sep 30, 2025 | $267.64K |
| Total Assets | Q2 2026 · Mar 31, 2026 | $15.05K |
| Total Assets | Q2 2026 · Sep 30, 2025 | $267.64K |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $76.59K |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $92.94K |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $18.53K |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $36.24K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $0 |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $0 |
| Net Income | Q2 2026 · Mar 31, 2026 | −$74.11K |
| Net Income | Q2 2026 · Mar 31, 2026 | −$91.13K |
| Net Income | Q2 2026 · Mar 31, 2025 | −$21.16K |
| Net Income restated | Q2 2026 · Mar 31, 2025 | −$41.49K |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$76.59K |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$92.94K |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$18.53K |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$36.24K |